GlassScriptPhysician profile
Katherine Eileen Christensen
NPI 1083693717
$5,145.42
in general payments reported to CMS, 2019-2025
15 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.76 · 2022: $1,864 · 2023: $325 · 2024: $1,653 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,739 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,738.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $525.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,428.88 | 2022-2025 | Watchman Flx, Therasphere Y90 Glass Microspheres 10 Gbq, General - Embolics |
| Medtronic, INC. | $2,116.83 | 2022-2025 | Cobalt Dr Mri Surescan, Linq II, Aurora Ev-Icd Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $120.57 | 2022-2024 | Lifevest |
| Amgen INC. | $88.76 | 2021-2025 | Repatha, Repatha |
| Novo Nordisk INC | $74.91 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $61.99 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $44.90 | 2022-2025 | Farxiga |
| Pfizer INC. | $44.49 | 2023 | |
| Merck Sharp & Dohme LLC | $38.62 | 2022-2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $27.55 | 2024 | |
| Genzyme Corporation | $26.08 | 2023 | |
| Irhythm Technologies, INC. | $22.56 | 2024 | Zio Monitor, Zio Xt Patch |
| Kiniksa Pharmaceuticals International, Plc | $18.87 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $15.43 | 2024 | Camzyos |
| Kiniksa Pharmaceuticals, LTD. | $14.98 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.